Compare Definium Therapeutics Inc. Common Shares (DFTX) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs PepsiCo, Inc. — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while PepsiCo, Inc. trades at $128.14 (market cap $168.88B). The key difference: PepsiCo, Inc. is far larger — about 35.9× Definium Therapeutics Inc. Common Shares's market cap, and PepsiCo, Inc. pays a 4.78% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and PepsiCo, Inc. for 107 Days on average.
| DFTX | PEP | |
|---|---|---|
Market Cap | $4.71B | $168.88B |
Volume | 1,966,636 | 13,263,972 |
Sector | Health | Consumer Staples |
52-Week High | $48.45 | $170.44 |
52-Week Low | $10.68 | $123.64 |
Typical Hold Time | 0 Days | 107 Days |
Enterprise Value | $3.67B | $211.38B |
Dividend Yield | — | 4.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PepsiCo (PEP) trades at $128.88, up 2.52% today, with strong earnings momentum as it has beaten EPS estimates for four consecutive quarters. The stock shows bearish technical signals from moving averages but bullish oscillators, trading near support at $123. Fundamentally, PEP maintains solid profitability with 10.78% net margin and 51.59% ROE, though revenue growth remains modest at 2.2% in 2025. Recent news highlights price adjustments on snack products to address consumer pushback on high prices.
PEP offers value with a 16.22 P/E below industry averages and a 12.7% upside to the $145.25 consensus target, supported by 30% analyst buy ratings. However, risks include competitive pressure, margin compression from pricing actions, and technical weakness. The company's consistent dividend and earnings beats provide stability, but investors should monitor North American sales recovery and inflation impacts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
